gene therapy: be effective on monogenic diseases

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.72
, chemotherapy
Weight: 0.66
, field
Weight: 0.64
, approach
Weight: 0.64
, application
Weight: 0.63
Siblings acupuncture
Weight: 0.35
, stimulation
Weight: 0.35
, medication
Weight: 0.35
, ablation
Weight: 0.34
, corticosteroid
Weight: 0.34

Related properties

Property Similarity
be effective on monogenic diseases 1.00
be effective on diseases 0.96
cause fungal infections 0.82
cure disease 0.82
cause infections 0.82
be with primaquine initiate hemolytic anemia 0.81
affect cancer cells 0.80
be contraindicated in fungal infections 0.79
increase risk of infection 0.78
be useful in treatment of glaucoma 0.78

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.51
Rule weight: 0.66
Evidence weight: 0.95
Similarity weight: 0.81
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia)
Evidence: 0.62
¬ Typical(gene therapy, be effective on monogenic diseases)
0.34
Rule weight: 0.66
Evidence weight: 0.65
Similarity weight: 0.80
Evidence: 0.44
Plausible(chemotherapy, affect cancer cells)
Evidence: 0.62
¬ Typical(gene therapy, be effective on monogenic diseases)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.86
Similarity weight: 0.80
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.44
¬ Plausible(chemotherapy, affect cancer cells)
0.05
Rule weight: 0.09
Evidence weight: 0.71
Similarity weight: 0.81
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.92
¬ Plausible(treatment, be with primaquine initiate hemolytic anemia)

Remarkability exclusitivity betweem a parent and a child

0.30
Rule weight: 0.58
Evidence weight: 0.63
Similarity weight: 0.81
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.45
¬ Remarkable(treatment, be with primaquine initiate hemolytic anemia)
0.11
Rule weight: 0.58
Evidence weight: 0.24
Similarity weight: 0.80
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.94
¬ Remarkable(chemotherapy, affect cancer cells)

Remarkability exclusitivity between siblings

0.07
Rule weight: 0.13
Evidence weight: 0.65
Similarity weight: 0.78
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.44
¬ Remarkable(acupuncture, be useful in treatment of glaucoma)
0.04
Rule weight: 0.13
Evidence weight: 0.42
Similarity weight: 0.78
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.71
¬ Remarkable(corticosteroid, increase risk of infection)
0.04
Rule weight: 0.13
Evidence weight: 0.40
Similarity weight: 0.82
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.74
¬ Remarkable(corticosteroid, cause fungal infections)
0.04
Rule weight: 0.13
Evidence weight: 0.38
Similarity weight: 0.79
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.77
¬ Remarkable(corticosteroid, be contraindicated in fungal infections)
0.04
Rule weight: 0.13
Evidence weight: 0.33
Similarity weight: 0.82
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.82
¬ Remarkable(corticosteroid, cause infections)

Remarkability from parent implausibility

0.34
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.81
Evidence: 0.92
Plausible(treatment, be with primaquine initiate hemolytic anemia)
Evidence: 0.81
Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.69
¬ Plausible(gene therapy, be effective on monogenic diseases)
0.31
Rule weight: 0.42
Evidence weight: 0.93
Similarity weight: 0.80
Evidence: 0.44
Plausible(chemotherapy, affect cancer cells)
Evidence: 0.81
Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.69
¬ Plausible(gene therapy, be effective on monogenic diseases)

Remarkability from sibling implausibility

0.48
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.82
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.82
Remarkable(corticosteroid, cause infections)
Evidence: 0.55
¬ Plausible(corticosteroid, cause infections)
0.47
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.82
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.74
Remarkable(corticosteroid, cause fungal infections)
Evidence: 0.71
¬ Plausible(corticosteroid, cause fungal infections)
0.45
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.79
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.77
Remarkable(corticosteroid, be contraindicated in fungal infections)
Evidence: 0.74
¬ Plausible(corticosteroid, be contraindicated in fungal infections)
0.45
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.78
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.71
Remarkable(corticosteroid, increase risk of infection)
Evidence: 0.55
¬ Plausible(corticosteroid, increase risk of infection)
0.42
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.78
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.44
Remarkable(acupuncture, be useful in treatment of glaucoma)
Evidence: 0.57
¬ Plausible(acupuncture, be useful in treatment of glaucoma)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.74
Similarity weight: 1.00
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.85
¬ Salient(gene therapy, be effective on monogenic diseases)

Similarity expansion

0.79
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.96
Evidence: 0.62
Typical(gene therapy, be effective on monogenic diseases)
Evidence: 0.10
¬ Typical(gene therapy, be effective on diseases)
0.74
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.96
Evidence: 0.85
Salient(gene therapy, be effective on monogenic diseases)
Evidence: 0.63
¬ Salient(gene therapy, be effective on diseases)
0.73
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.96
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.35
¬ Plausible(gene therapy, be effective on diseases)
0.67
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.96
Evidence: 0.81
Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.96
¬ Remarkable(gene therapy, be effective on diseases)
0.61
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.82
Evidence: 0.85
Salient(gene therapy, be effective on monogenic diseases)
Evidence: 0.86
¬ Salient(gene therapy, cure disease)
0.60
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.82
Evidence: 0.81
Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.76
¬ Remarkable(gene therapy, cure disease)
0.54
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.82
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.74
¬ Plausible(gene therapy, cure disease)
0.51
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.82
Evidence: 0.62
Typical(gene therapy, be effective on monogenic diseases)
Evidence: 0.71
¬ Typical(gene therapy, cure disease)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.85
Salient(gene therapy, be effective on monogenic diseases)
Evidence: 0.62
¬ Typical(gene therapy, be effective on monogenic diseases)
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.69
Plausible(gene therapy, be effective on monogenic diseases)
Evidence: 0.62
¬ Typical(gene therapy, be effective on monogenic diseases)

Typicality and Rermarkability incompatibility between a parent and a child

0.33
Rule weight: 0.51
Evidence weight: 0.81
Similarity weight: 0.80
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.24
¬ Typical(chemotherapy, affect cancer cells)
0.08
Rule weight: 0.51
Evidence weight: 0.20
Similarity weight: 0.81
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.98
¬ Typical(treatment, be with primaquine initiate hemolytic anemia)

Typicality and Rermarkability incompatibility between siblings

0.07
Rule weight: 0.14
Evidence weight: 0.62
Similarity weight: 0.82
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.47
¬ Typical(corticosteroid, cause infections)
0.06
Rule weight: 0.14
Evidence weight: 0.57
Similarity weight: 0.78
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.53
¬ Typical(corticosteroid, increase risk of infection)
0.05
Rule weight: 0.14
Evidence weight: 0.44
Similarity weight: 0.82
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.69
¬ Typical(corticosteroid, cause fungal infections)
0.05
Rule weight: 0.14
Evidence weight: 0.45
Similarity weight: 0.78
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.68
¬ Typical(acupuncture, be useful in treatment of glaucoma)
0.04
Rule weight: 0.14
Evidence weight: 0.42
Similarity weight: 0.79
Evidence: 0.81
¬ Remarkable(gene therapy, be effective on monogenic diseases)
Evidence: 0.72
¬ Typical(corticosteroid, be contraindicated in fungal infections)

Typicality inheritance from parent to child

0.35
Rule weight: 0.48
Evidence weight: 0.91
Similarity weight: 0.80
Evidence: 0.62
Typical(gene therapy, be effective on monogenic diseases)
Evidence: 0.24
¬ Typical(chemotherapy, affect cancer cells)
0.25
Rule weight: 0.48
Evidence weight: 0.63
Similarity weight: 0.81
Evidence: 0.62
Typical(gene therapy, be effective on monogenic diseases)
Evidence: 0.98
¬ Typical(treatment, be with primaquine initiate hemolytic anemia)